Literature DB >> 1960414

Determination of immunoreactive fraction and kinetic parameters of a radiolabeled monoclonal antibody in the absence of antigen excess.

R Dux1, A Kindler-Röhrborn, K Lennartz, M F Rajewsky.   

Abstract

Monoclonal antibodies (Mabs) directed against cell surface determinants and conjugated to fluochromes, radionuclids or drugs are of increasing importance in cell and tumor biology as well as in clinical oncology. Many of the applications of Mab require precise and quantitative information regarding the molecular interactions of labeled antibody with the respective antigen expressed on the cell surface. These interactions are characterized by the association rate constant (ka), the dissociation rate constant (kd) and the antibody affinity constant (K). The immunoreactive fraction (IRF) of the labeled antibody molecules directly influences these parameters. IRF is usually reduced below 100% by antibody purification and labeling procedures and, in case of radiolabeled antibodies, by radiation damage during antibody storage. Besides the calculation of kinetic parameters, IRF should, therefore, be determined for the quality control of any antibody preparation before experimental or clinical application. Commonly used methods for measuring IRF are based on radioimmunoassays (RIA) on intact cells performed under antigen excess. However, especially with Mabs directed against cell surface antigens expressed in small numbers per cell and for displaying low affinity constants, these assays often give unsatisfactory results. We have, therefore, established a method which permits us to determine IRF, ka, kd and K for an 125I-labeled Mab with precision even in the absence of antigen excess.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960414     DOI: 10.1016/0022-1759(91)90084-s

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals.

Authors:  Sai Kiran Sharma; Serge K Lyashchenko; Hijin A Park; Nagavarakishore Pillarsetty; Yorann Roux; Jiong Wu; Sophie Poty; Kathryn M Tully; John T Poirier; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2019-05-03       Impact factor: 2.408

2.  A monoclonal antibody extends the half-life of an anti-HIV oligodeoxynucleotide and targets it to CD4+ cells.

Authors:  D Morelli; B Pozzi; J A Maier; S Ménard; M I Colnaghi; A Balsari
Journal:  Nucleic Acids Res       Date:  1995-11-25       Impact factor: 16.971

Review 3.  Does the Number of Bifunctional Chelators Conjugated to a mAb Affect the Biological Activity of Its Radio-Labeled Counterpart? Discussion Using the Example of mAb against CD-20 Labeled with 90Y or 177Lu.

Authors:  Urszula Karczmarczyk; Agnieszka Sawicka; Piotr Garnuszek; Michał Maurin; Wioletta Wojdowska
Journal:  J Med Chem       Date:  2022-04-20       Impact factor: 8.039

4.  A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems.

Authors:  Thibaut Denoël; Luca Pedrelli; Giuseppe Pantaleo; John O Prior
Journal:  Pharmaceuticals (Basel)       Date:  2019-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.